The significance of cell type and tumor growth markers in the prognosis of unscreened cervical cancer patients

International Journal of Gynecological Cancer

Volumn 8, Issue 4, 1998, Pages 336-344

  Ter Harmsel, B ^a   Van Muyden, R ^a   Smedts, F ^b   Hermans, J ^c   Kuijpers, J ^a   Raikhlin, N ^d   Petrov, S ^e   Lebedev, A ^d   Ramaekers, F ^f   Trimbos, B ^c  

^a Reinier de Graaf Gasthuis ^*  (Netherlands)

^b Foundation of Collaborating Hospital   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d Cancer Research Center   (Russian Federation)

^e KAZAN STATE MEDICAL UNIVERSITY   (Russian Federation)

^f MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Adenocarcinoma; BCL 2; Ki 67 Ag; p53; Squamous cell carcinoma; Survival; Tumor stage

Indexed keywords

ARTICLE; CANCER SURVIVAL; CELL TYPE; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; RUSSIAN FEDERATION; TUMOR GROWTH; UTERINE CERVIX CANCER;

EID: 0031694140     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.1998.09796.x     Document Type: Article

References (21)

1. Reinthaller A, Tatra G, Breitneckcr G, Janish H. Prognose faktoren beim invasiven Zervixkarzinom der Stadien Ia-IIb nach radikaler Hysterektomie unter besonderer Berucksichtigung der Stromareaktion. Geburtsh u Frauenheik 1991; 51: 809-13.
2. Inoue T, Okumura M. Prognostic sinificance of parametrial extension in patient with cervical carcinoma stages IB, IIA and IIB. Cancer 1984; 54: 1714-9.
3. Inoue T, Casanova HA, Morita K, Chihara T. The prognostic significance of the minimum thickness of uninvolved cervix in patients with cervical carcinoma stages IB, IIA and IIB. Gynecol Oncol 1986; 24: 220-9.
4. Buckley CH, Beards CS, Fox H. Pathological prognostic indicators in cervical cancer with particular reference to patients under the age of 40 years. Br J Obstet Gynaecol 1988; 95: 47-56.
5. Wentz W, Reagan JW. Survival in cervical cancer with respect to cell type. Cancer 1959; 12: 384-8.
6. Crissman JD, Makuch R, Budhraja M. Histopathologic grading of squamous cell carcinoma of the uterine cervix. Cancer 1985; 55: 1590-6.
7. Brinton LA, Herrero R, Reeves WC, Britton RC, Gaitan E, Tenorio F. Risk factors of cervical cancer by histology. Gynecol Oncol 1993; 51: 301-6.
8. Eifel PJ, Burke TW, Morris M, Smith TL. Adenocarcinoma as an independent risk factor for disease recurrence in patients with stage IB cervical carcinoma. Gynecol Oncol 1995; 59: 38-44.
9. Van Nagell JR Jr, Powell De Gallion HH et al. Small cell carcinoma of the uterine cervix. Cancer 1988; 62: 1586-93.
10. Hopkins MP, Morley GW. A comparison of adenocarcinoma and squamous cell carcinoma of the cervix. Obstet Gynecol 1991; 77: 912-7.
11. Jaworski RC. Endocervical glandular dysplasia, adenocarcinoma in situ, and early invasive (microinvasive) adenocarcinoma of the uterine cervix. Sem Diag Pathol 1990; 7: 190-04.
12. Buckley CH, Fox H. Carcinoma of the cervix. In: Anthony, PP., Macsween RNM. eds Recent advances in histopathology Vol. 14. Edinburgh, London, Melbourne and New York: Churchill Livingstone, 1989; 63-78.
13. Mitchell MF, Hittelman WK, Lotan R, Nishioka K, Tortolero-Luna G, Richards-Kortum R, Wharton JT, Hong WK. Chemoprevention trials and surrogate end point markers in the cervix. Cancer 1995; 76: 1956-77.
14. ter Harmsel B, Kuijpers J, Smedts F, Jeunink M, Trimbos B, Ramaekers F. Progressing imbalance between proliferation and apoptosis with increasing severity of cervical intraepithelial neoplasia. Int J Gynecol Pathol 1997; 16: 205-11.
15. Hockenberry D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ. BCL-2 is an inner mitochondral membrane protein that blocks programmed cell death. Nature 1990; 348: 334-6.
16. Hockenberry DM, Zutter M, Hickey W, Nahm M, Korsmeyer SJ, BCL. -2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 1991; 88: 6961-5.
17. Wyllie AH. Apoptosis and carcinogenesis. Eur J Cell Biol 1997; 73: 189-97.
18. Lane DP, Benchimol S. p53: Oncogene or anti-oncogene? Genes Dev 1990; 4: 1-8.
19. Xiao-Feng Sun Carstensen JM, Zhang H, Stal O, Wingren S, Hatschek T, Nordenskjold B. Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma. Lancet 1992; 340: 1369-73.
20. Hall PA, Lane DP. P53 in tumour pathology: can we trust immunohistochemistry?-Revisited. J Path 1994; 172: 1-4.
21. Zheng W, Cao P, Zheng M, Kramer EE, Godwin TA. p53 overexpression and bcl-2 persistence in endometrial carcinoma: comparison of papillary serous and endometroid subtypes. Gynecol Oncol 1996; 61: 167-74.